Free Trial

Retractable Technologies (RVP) Competitors

Retractable Technologies logo
$0.64 +0.02 (+2.75%)
(As of 12/20/2024 05:16 PM ET)

RVP vs. APYX, HSAQ, DHAI, INO, MODD, CTSO, NVNO, ICAD, LUCD, and ICCM

Should you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include Apyx Medical (APYX), Health Sciences Acquisitions Co. 2 (HSAQ), DIH Holding US (DHAI), Inovio Pharmaceuticals (INO), Modular Medical (MODD), Cytosorbents (CTSO), enVVeno Medical (NVNO), iCAD (ICAD), Lucid Diagnostics (LUCD), and IceCure Medical (ICCM). These companies are all part of the "surgical & medical instruments" industry.

Retractable Technologies vs.

Apyx Medical (NASDAQ:APYX) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, community ranking, institutional ownership, valuation, media sentiment and dividends.

Apyx Medical has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 1.98, indicating that its stock price is 98% more volatile than the S&P 500.

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 16.8% of Apyx Medical shares are owned by insiders. Comparatively, 55.0% of Retractable Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Retractable Technologies has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apyx Medical$48.54M1.22-$18.71M-$0.83-1.89
Retractable Technologies$38.27M0.50-$7.01M-$0.54-1.19

Retractable Technologies has a net margin of -41.11% compared to Apyx Medical's net margin of -58.59%. Retractable Technologies' return on equity of -17.15% beat Apyx Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Apyx Medical-58.59% -137.98% -36.74%
Retractable Technologies -41.11%-17.15%-9.33%

Apyx Medical received 78 more outperform votes than Retractable Technologies when rated by MarketBeat users. Likewise, 60.94% of users gave Apyx Medical an outperform vote while only 0.00% of users gave Retractable Technologies an outperform vote.

CompanyUnderperformOutperform
Apyx MedicalOutperform Votes
78
60.94%
Underperform Votes
50
39.06%
Retractable TechnologiesOutperform Votes
No Votes
Underperform Votes
77
100.00%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apyx Medical
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.67
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Apyx Medical and Apyx Medical both had 1 articles in the media. Retractable Technologies' average media sentiment score of 0.50 beat Apyx Medical's score of 0.00 indicating that Retractable Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Apyx Medical Neutral
Retractable Technologies Positive

Summary

Retractable Technologies beats Apyx Medical on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVP vs. The Competition

MetricRetractable TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$18.65M$4.36B$5.06B$19.18B
Dividend YieldN/A41.46%4.84%3.58%
P/E Ratio-1.1925.01102.6741.22
Price / Sales0.5045.671,121.7417.58
Price / Cash36.9743.4641.3021.28
Price / Book0.197.364.745.32
Net Income-$7.01M$13.64M$119.11M$989.67M
7 Day Performance0.63%-2.82%-1.86%-3.45%
1 Month Performance6.88%0.54%11.37%-3.73%
1 Year Performance-43.86%41.80%30.22%12.06%

Retractable Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVP
Retractable Technologies
N/A$0.64
+2.7%
N/A-43.4%$18.65M$38.27M-1.19148Analyst Forecast
APYX
Apyx Medical
1.6647 of 5 stars
$1.78
+6.0%
N/A-37.2%$67.01M$48.54M-2.23270Positive News
HSAQ
Health Sciences Acquisitions Co. 2
N/A$5.26
-1.5%
N/A-51.8%$58.98MN/A0.004Gap Down
DHAI
DIH Holding US
N/A$1.41
+0.7%
N/AN/A$57.17M$64.47M0.00N/A
INO
Inovio Pharmaceuticals
3.3255 of 5 stars
$2.10
-9.5%
$38.00
+1,709.5%
-96.7%$54.81M$203,413.000.00127High Trading Volume
MODD
Modular Medical
3.1757 of 5 stars
$1.54
-3.1%
$5.00
+224.7%
-14.7%$53.42MN/A-2.5239News Coverage
CTSO
Cytosorbents
2.5619 of 5 stars
$0.97
-3.5%
$2.00
+105.2%
-50.3%$53.29M$33.79M-2.81186Analyst Forecast
Positive News
Gap Down
NVNO
enVVeno Medical
1.3856 of 5 stars
$2.82
-1.1%
N/A-45.5%$49.45MN/A-2.1919Gap Up
ICAD
iCAD
0.2943 of 5 stars
$1.83
-6.4%
N/A+10.9%$48.44M$18.94M-15.0067
LUCD
Lucid Diagnostics
2.1501 of 5 stars
$0.81
+3.2%
$3.63
+347.3%
-43.0%$48.10M$4.19M-0.6970News Coverage
High Trading Volume
ICCM
IceCure Medical
2.8631 of 5 stars
$1.01
-6.0%
$2.70
+168.4%
+21.7%$45.89M$3.67M-3.6971

Related Companies and Tools


This page (NYSE:RVP) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners